Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypes.
about
Stable expression of human H1-histamine-receptor cDNA in Chinese hamster ovary cells. Pharmacological characterisation of the protein, tissue distribution of messenger RNA and chromosomal localisation of the geneModulation of the conformational state of the SV2A protein by an allosteric mechanism as evidenced by ligand binding assays.Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failureGene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex.Transplantation of a 17-amino acid alpha-helical DNA-binding domain into an antibody molecule confers sequence-dependent DNA recognitionToxicokinetics, including saturable protein binding, of 4-chloro-2-methyl phenoxyacetic acid (MCPA) in patients with acute poisoning.Characterization and distribution of putative 5-ht7 receptors in guinea-pig brainQuantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatumDermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat.Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor.Na⁺,K⁺-ATPase as the Target Enzyme for Organic and Inorganic Compounds.A comprehensive method for the quantitative determination of dopamine receptor subtypes.Acute reduction in human platelet alpha 2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholamines.Beta-adrenoceptor desensitization during the development of canine pacing-induced heart failure.Radioligand binding characteristics of beta 2-adrenoceptors of cultured melanoma cells.Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.Interaction between gallopamil and cardiac ryanodine receptors.Three distinct binding sites for [3H]-prazosin in the rat cerebral cortex.Human beta-adrenergic receptors. Simultaneous purification of beta 1- and beta 2-adrenergic-receptor peptides.Selective distinction at equilibrium between the two alpha-neurotoxin binding sites of Torpedo acetylcholine receptor by microtitration.Sarcolemmal beta-adrenoceptors determined in rat ventricular heart biopsies with (-)-[3H]CGP-12177.A kinetic analysis of kappa-opioid agonist binding using the selective radioligand [3H]U69593.Effects of digoxin and gitoxin on the enzymatic activity and kinetic parameters of Na+/K+-ATPase.Biochemical and pharmacological characterization of the binding of the selective peptide-leukotriene antagonist, 3H-ICI 198,615, to leukotriene D4 receptors in guinea-pig lung membranes.Characteristics of [3H]hemicholinium-3 binding to rat striatal membranes: evidence for negative cooperative site-site interactions.Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.Multiple [35S]t-butylbicyclophosphorothionate binding sites in rat and chicken cerebral hemispheres.CL 218,872 binding to benzodiazepine receptors in rat spinal cord: modulation by gamma-aminobutyric acid and evidence for receptor heterogeneity.Investigation on central dopaminergic receptors (D-2) using the antagonistic properties of new benzamides.A method for dissecting two site receptor interactions in ligand binding studies.Buprenorphine: high-affinity binding to dorsal spinal cord.Pharmacological evidence for beta2-adrenoceptor in right atria from stressed female rats.Comparison of 125I-SCH 23982 and [3H]SCH 23390 as ligands for the D-1 dopamine receptor.
P2860
Q24322039-ABFFD2C7-14FB-40FE-BB55-F010B0B75D6DQ30435547-24C3FCC4-45EE-458A-8C86-3E72BBA05759Q33892916-DC9209C8-20ED-4046-BDB7-844A7FED1D57Q34185733-3AADE22B-895D-494E-B694-B3C41C487E6EQ34298787-4D80AA1D-AB8E-4844-A199-F089ACCDDC95Q34694804-45C48FC3-A86A-46E5-B419-7E6C297923ABQ35872549-D9059E32-1658-4076-AC8B-32D0392B4AE7Q36325082-71FC15CF-F12A-43A6-A1F7-1E30926D99B3Q37140069-6C79CB55-E8EF-4546-A24E-C73C3242785AQ38712373-C5CA1F06-15D6-41D6-A277-C95383A2E646Q39016538-517BBE9B-7631-401F-9655-7BAE6DEE1A5FQ40143480-3E7FD55F-AC5E-4420-94D2-3F38D0BE985CQ40682252-1966E965-2419-4E17-BF33-77733A6A4CBFQ41183380-A5F1EF96-2327-4DBB-A62A-1C915018AE64Q41727260-E332C916-079A-45EB-925E-8212D9D972BFQ41915672-13255682-C720-4F05-A249-D6BC0C5E6072Q42137974-35FC3CF3-EA58-4153-8A28-EABB83003FAEQ42181237-79D18027-BB2F-4C5A-AAED-C74F4440F049Q42501456-1CE0743B-3DED-41FC-9A29-0376E6A28A68Q42658392-5703D170-4332-4A01-BE95-180DAF7B09BCQ44279875-08BB5ECD-A228-425F-9E33-D6FEB38F1BF0Q44341647-57D78929-9516-4142-9F64-9796FA7F97EAQ45222509-AE85F156-D362-47C1-B21F-5440EE141AF1Q46921890-D15433CB-F9A9-4693-92F4-CF4DCF111C96Q48199346-57A64DB0-D4AF-4D1D-B694-BF0DADAF27ACQ48383809-A54BD48B-5B32-4608-804E-0608A38CB2C1Q48448652-9C22BF7C-5D9C-4AB5-A719-C0660CE95C14Q48620899-5BE82648-04B4-43CB-88B9-73DD48AF0ECEQ48666665-E18B8971-747D-4D9A-AD35-F09A91AB839AQ48842395-7D804F28-E673-4BB1-961C-A4D70BF62F4CQ48941464-04D3B564-BF31-4C57-9B82-00201E74D900Q52139549-4BD2B172-056B-431C-B1C5-183C3872F31EQ52558236-04745B3D-0B86-45AF-8606-5330061ACC6E
P2860
Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypes.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Quantitative analysis of drug- ...... operties of receptor subtypes.
@en
type
label
Quantitative analysis of drug- ...... operties of receptor subtypes.
@en
prefLabel
Quantitative analysis of drug- ...... operties of receptor subtypes.
@en
P2093
P1433
P1476
Quantitative analysis of drug- ...... operties of receptor subtypes.
@en
P2093
P304
P356
10.1016/0024-3205(81)90208-3
P407
P577
1981-08-01T00:00:00Z